COMMUNIQUÉS West-GlobeNewswire

iKang Announces Buyer Group’s Re-Evaluation of Merger and Request for Extension of Termination Date
07/09/2018
BEIJING, Sept. 07, 2018 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, today announced [...]
GBT Announces Participation at the 2018 Morgan Stanley Global Healthcare Conference
07/09/2018
SOUTH SAN FRANCISCO, Calif., Sept. 07, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will present at the 2018 Morgan Stanley Global Healthcare Conference in New [...]
Burcon Announces Results of Shareholder Meeting
07/09/2018
VANCOUVER, British Columbia, Sept. 07, 2018 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX: BU) a leader in functional, renewable plant-based proteins, is pleased to announce the results from its 2018 annual [...]
National Brain Tumor Society Issues Tip Sheet on Pediatric Brain Cancer for Childhood Cancer Awareness Month
07/09/2018
Newton, MA , Sept. 07, 2018 (GLOBE NEWSWIRE) -- September is national Childhood Cancer Awareness Month, and given brain tumors are the second most common group of childhood cancers and the leading cause of cancer deaths [...]
UPDATE -- Golden Leaf Holdings Adds Chief Marketing and Sales Officer to Business Development Team
07/09/2018
Jeff Yapp joins as Chief Marketing and Sales Officer to bolster business development team and strengthen Company’s brand recognition and customer relations TORONTO, Sept. 07, 2018 (GLOBE NEWSWIRE) -- Golden Leaf [...]
Adaptimmune Therapeutics plc Announces Closing of Registered Direct Offering of American Depositary Shares
07/09/2018
PHILADELPHIA, Pa. and OXFORD, U.K., Sept. 07, 2018 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (“Adaptimmune”) (Nasdaq: ADAP), a leader in T-cell therapy to treat cancer, today announced the closing of its [...]
HEXO Corp. confirme qu’il n’y a pas de changement important
07/09/2018
GATINEAU, Québec, 07 sept. 2018 (GLOBE NEWSWIRE) -- À la demande de l’OCRCVM, HEXO Corp. (« HEXO » ou la « Société ») (TSX: HEXO ) désire confirmer qu’elle n’est pas au courant de tout développement corporatif d’ [...]
DBV Technologies: Monthly information regarding the total number of voting rights and total number of shares of the Company
07/09/2018
Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris [...]
DBV Technologies : Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social
07/09/2018
Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) Place de cotation : NYSE Euronext [...]
Samuel Ashu, Pharm.D., is Elected to the American Health Council’s Industry Board
07/09/2018
NEW YORK, Sept. 07, 2018 (GLOBE NEWSWIRE) -- The American Health Council elected Samuel Ashu, Pharm.D., to its Industry Board for his outstanding contributions to the pharmaceutical field. Currently serving as vice- [...]
Dyadic International Announces Research Collaboration with Sanofi-Aventis
07/09/2018
JUPITER, Fla., Sept. 07, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform [...]
HEXO Corp. confirms no material change
07/09/2018
GATINEAU, Quebec, Sept. 07, 2018 (GLOBE NEWSWIRE) -- HEXO Corp. (“HEXO” or the “Company”) (TSX:HEXO), at the request of IIROC, wishes to confirm that it is not aware of any material corporate development, material news [...]
LeMaitre Vascular to Present at Upcoming Investor Conferences
07/09/2018
BURLINGTON, Mass., Sept. 07, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be presenting at four conferences in September. David Roberts, President, will participate in the [...]
Auxly Announces Definitive International Supply Agreement With Aphria
07/09/2018
VANCOUVER, British Columbia, Sept. 07, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (OTCQX - CBWTF) (" Auxly " or the " Company ") is pleased to announce that further to its previously announced [...]
Tabula Rasa HealthCare Announces TRHC 2.0: Innovative Integrations, Interoperability and Advanced Healthcare Analytics
07/09/2018
Through accretive acquisitions and continued research and development, TRHC’s technology innovations and growing data lake provide a data continuum for clients enhancing the care of patients across the U.S. and abroad [...]
Oryzon receives approval to begin REIMAGINE: a Phase IIa clinical trial with Vafidemstat (ORY-2001) in aggressiveness
07/09/2018
The approval has been granted by the Spanish Medicines Agency The study will be done in patients with 3 psychiatric disorders and 2 neurodegenerative disorders This is the first Phase IIa study with Vafidemstat (ORY- [...]
First Choice Healthcare Solutions Announces Appointment of Mr. James Renna, Dr. Thomas Gill and Mr. Gary Augusta to Board of Directors
07/09/2018
MELBOURNE, Fla., Sept. 07, 2018 (GLOBE NEWSWIRE) -- First Choice Healthcare Solutions, Inc. (OTCQB:FCHS) ("First Choice" or the "Company"), a fully integrated, non-physician-owned, publicly traded healthcare delivery [...]
Portola Pharmaceuticals Announces Executive Leadership Change
07/09/2018
SOUTH SAN FRANCISCO, Calif., Sept. 07, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA) today announced that Tao Fu, chief commercial officer, has resigned effective September 21, 2018 to pursue [...]
Sarepta Therapeutics to Recognize World Duchenne Awareness Day at NASDAQ Opening Bell Ceremony
07/09/2018
CAMBRIDGE, Mass., Sept. 07, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a global biopharmaceutical company focused on the discovery and development of precision genetic medicines for the [...]

Pages